Abstract
BackgroundEarly concurrent antibiotic usage in patients receiving immune checkpoint inhibitors (ICIs) is linked to decreased progression-free survival (PFS) and overall survival (OS), likely mediated by lower gut microbial diversity and...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
